
Enzyre
Near Patient Diagnostics Focused on Blood Coagulation
Enzyre is a healthcare company in Nijmegen, Netherlands. It has raised $11.9M across 1 round, most recently an $11.9M Series A in November 2022.
- Headquarters
- Nijmegen
- Website
- enzyre.com
- Total Funding
- $11.9M
- Last Round
- $11.9M Series ANov 2022
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Enzyre develops near-patient diagnostics focused on blood coagulation. Its ENZYSYSTEM combines a blood sampling device, a single-use microfluidic cartridge and a reusable processor controlled by a mobile phone app. The system processes test results and transfers them to the cloud, making coagulation data available to authorized healthcare professionals managing patient therapy.
Summary
It has raised $11.9M in total across 1 round, most recently a $11.9M Series A round in Nov 2022. Investors include i&i Biotech Fund.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2022
Investors
Similar Companies
Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
China's leading blood products manufacturer
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/enzyre"><img src="https://indexed.vc/api/badge/company/enzyre" alt="Enzyre on Indexed.vc" width="260" height="76" /></a>
